Reference health
Mesoporous Silica Nanoparticles for Increasing the Oral Bioavailability and Permeation of Poorly Water Soluble Drugs
40/40 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 40 checked references that resolve
resolves10.1016/j.drudis.2007.09.005
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
resolves10.1016/S0169-409X(00)00129-0
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
resolves10.1146/annurev.pharmtox.40.1.133
High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug Discovery
resolves10.1021/mp050095h
Scientific Perspectives on Drug Transporters and Their Role in Drug Interactions
resolves10.1016/j.addr.2007.05.003
Nanosizing — Oral formulation development and biopharmaceutical evaluation
resolves10.1021/mp100356k
Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells
resolves10.1038/nmat2398
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
resolves10.1021/mp9002865
Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell Growth
resolves10.1038/nature01362
Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica
resolves10.1016/j.addr.2008.03.012
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
resolves10.1016/j.jconrel.2008.02.013
Towards establishing structure–activity relationships for mesoporous silica in drug delivery applications
resolves10.1016/j.jconrel.2009.03.017
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
resolves10.1002/adfm.200601191
Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications
resolves10.1016/j.jconrel.2009.07.015
Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release
resolves10.1016/j.jconrel.2005.10.020
Controlled release of avermectin from porous hollow silica nanoparticles: Influence of shell thickness on loading efficiency, UV-shielding property and release
resolves10.1016/j.ejpb.2003.12.007
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property
resolves10.1016/j.jconrel.2005.08.017
Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs
resolves10.1016/j.micromeso.2009.04.013
Mesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipine
resolves10.1016/j.ijpharm.2009.12.023
Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles
resolves10.1021/la801161g
Physical State of Poorly Water Soluble Therapeutic Molecules Loaded into SBA-15 Ordered Mesoporous Silica Carriers: A Case Study with Itraconazole and Ibuprofen
resolves10.1016/j.ijpharm.2010.07.040
Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: Drug loading and release properties
resolves10.1016/j.biomaterials.2007.10.019
Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems
resolves10.1016/j.micromeso.2003.12.012
Influence of pore size of MCM-41 matrices on drug delivery rate
resolves10.1016/j.jconrel.2010.04.029
Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan
resolves10.1126/science.279.5350.548
Triblock Copolymer Syntheses of Mesoporous Silica with Periodic 50 to 300 Angstrom Pores
resolves10.1016/j.jconrel.2008.04.001
Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release
resolves10.1021/nn103077k
Interaction of Mesoporous Silica Nanoparticles with Human Red Blood Cell Membranes: Size and Surface Effects
resolves10.1016/j.biomaterials.2010.01.015
An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles
resolves10.1021/mp900253n
The Drug Transporter−Metabolism Alliance: Uncovering and Defining the Interplay
resolves10.1021/nn100690m
Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line
resolves10.1021/mp1003493
Improvement of the Dissolution Rate of Poorly Soluble Drugs by Solid Crystal Suspensions
The 1 reference without a DOI — listed, not checked
no DOI — not checkedref6/cit6
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1021/mp200287c"><img src="https://citestamp.com/citestamped/10.1021/mp200287c/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1021/mp200287c)